• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.

作者信息

Chun Hyung J, Bonnet Sébastien, Chan Stephen Y

机构信息

1 Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut.

2 Pulmonary Hypertension Research Group, Quebec Heart and Lung Institute Research Centre, University of Laval, Quebec City, Quebec, Canada; and.

出版信息

Am J Respir Crit Care Med. 2017 Jan 15;195(2):167-178. doi: 10.1164/rccm.201604-0886PP.

DOI:10.1164/rccm.201604-0886PP
PMID:27648944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5394787/
Abstract
摘要

相似文献

1
Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.肺动脉高压领域的转化医学进展。肺动脉高压中微小RNA生物学的转化。这需要的不仅仅是“miR”这个词。
Am J Respir Crit Care Med. 2017 Jan 15;195(2):167-178. doi: 10.1164/rccm.201604-0886PP.
2
MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.微小RNA-143激活调节肺动脉高压中平滑肌细胞与内皮细胞的相互作用
Circ Res. 2015 Oct 23;117(10):870-883. doi: 10.1161/CIRCRESAHA.115.306806. Epub 2015 Aug 26.
3
MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.微小 RNA-424(322) 作为肺动脉高压疾病进展的新标志物及其通过靶向 SMURF1 作用于右心室肥厚的机制。
Cardiovasc Res. 2018 Jan 1;114(1):53-64. doi: 10.1093/cvr/cvx187.
4
Epigenetics: novel mechanism of pulmonary hypertension.表观遗传学：肺动脉高压的新机制。
Lung. 2013 Dec;191(6):601-10. doi: 10.1007/s00408-013-9505-1. Epub 2013 Sep 20.
5
MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β.微小RNA-103/107通过靶向低氧诱导因子-1β参与低氧诱导的肺动脉平滑肌细胞增殖。
Life Sci. 2016 Feb 15;147:117-24. doi: 10.1016/j.lfs.2016.01.043. Epub 2016 Jan 29.
6
Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension.血管生成受损和外周肌肉微循环丧失导致肺动脉高压运动耐量下降。
Am J Respir Crit Care Med. 2014 Aug 1;190(3):318-28. doi: 10.1164/rccm.201402-0383OC.
7
MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.微小RNA-138和微小RNA-25下调线粒体钙单向转运体，导致肺动脉高压癌症表型。
Am J Respir Crit Care Med. 2017 Feb 15;195(4):515-529. doi: 10.1164/rccm.201604-0814OC.
8
Human lung microRNA profiling in pulmonary arterial hypertension secondary to congenital heart defect.先天性心脏病继发肺动脉高压患者的人肺微小RNA谱分析
Pediatr Pulmonol. 2015 Dec;50(12):1214-23. doi: 10.1002/ppul.23181. Epub 2015 Apr 2.
9
Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension.微小RNA调控在肺动脉高压中的治疗潜力
Curr Vasc Pharmacol. 2015;13(3):331-40. doi: 10.2174/15701611113119990010.
10
Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.肺动脉高压领域的转化进展 肺动脉高压的分子医学。从群体遗传学到精准医学和基因编辑。
Am J Respir Crit Care Med. 2017 Jan 1;195(1):23-31. doi: 10.1164/rccm.201605-0905PP.

引用本文的文献

1
HNRNPA2B1: a novel target in pulmonary arterial hypertension.HNRNPA2B1：肺动脉高压的一个新靶点。
Front Cardiovasc Med. 2025 Jul 9;12:1497938. doi: 10.3389/fcvm.2025.1497938. eCollection 2025.
2
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension.支持肺动脉高压分类的诊断性微小RNA特征
Circ Genom Precis Med. 2025 Jun;18(3):e004862. doi: 10.1161/CIRCGEN.124.004862. Epub 2025 Apr 18.
3
MicroRNA in pediatric pulmonary hypertension microRNA profiling to inform disease classification, severity, and treatment response in pediatric pulmonary hypertension.小儿肺动脉高压中的微小RNA 微小RNA分析用于指导小儿肺动脉高压的疾病分类、严重程度及治疗反应
Am J Physiol Heart Circ Physiol. 2025 Jan 1;328(1):H47-H57. doi: 10.1152/ajpheart.00622.2024. Epub 2024 Nov 26.
4
Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.苏根/低氧诱导的大鼠肺动脉高压的生物学和药理学的最新概述。
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):241-283. doi: 10.1089/jamp.2024.0016.
5
Identification and experimental verification of senescence-related gene signatures and molecular subtypes in idiopathic pulmonary arterial hypertension.特发性肺动脉高压中衰老相关基因特征和分子亚型的鉴定和实验验证。
Sci Rep. 2024 Sep 27;14(1):22157. doi: 10.1038/s41598-024-72979-8.
6
An individualized Bayesian method for estimating genomic variants of hypertension.一种用于估计高血压基因组变异的个体化贝叶斯方法。
BMC Genomics. 2023 Nov 7;23(Suppl 5):863. doi: 10.1186/s12864-023-09757-9.
7
Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension.微小RNA 21、124及其他新型生物标志物在区分世界卫生组织第1组肺动脉高压与第2、3组世界卫生组织肺动脉高压中的作用。
Egypt Heart J. 2023 Aug 30;75(1):76. doi: 10.1186/s43044-023-00395-w.
8
Circulating Microparticles Are Differentially Increased in Lowlanders and Highlanders with High Altitude Induced Pulmonary Hypertension during the Cold Season.在寒冷季节，高原肺动脉高压的低海拔和高海拔人群中，循环微颗粒水平差异增加。
Cells. 2022 Sep 20;11(19):2932. doi: 10.3390/cells11192932.
9
The Landscape of Noncoding RNA in Pulmonary Hypertension.非编码 RNA 在肺动脉高压中的全景。
Biomolecules. 2022 Jun 7;12(6):796. doi: 10.3390/biom12060796.
10
Kynurenine-PARP-1 Link Mediated by MicroRNA 210 May Be Dysregulated in Pulmonary Hypertension.犬尿氨酸-PARP-1 可能通过 microRNA 210 介导在肺动脉高压中失调。
Anatol J Cardiol. 2022 May;26(5):388-393. doi: 10.5152/AnatolJCardiol.2021.861.

本文引用的文献

1
Functional Analysis of miRNAs Using the DIANA Tools Online Suite.使用DIANA工具在线套件对微小RNA进行功能分析
Methods Mol Biol. 2017;1517:25-50. doi: 10.1007/978-1-4939-6563-2_2.
2
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension.血管僵硬通过机械激活YAP/TAZ依赖的谷氨酰胺分解来驱动肺动脉高压。
J Clin Invest. 2016 Sep 1;126(9):3313-35. doi: 10.1172/JCI86387. Epub 2016 Aug 22.
3
DNA Damage and Pulmonary Hypertension.DNA损伤与肺动脉高压
Int J Mol Sci. 2016 Jun 22;17(6):990. doi: 10.3390/ijms17060990.
4
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.微小RNA-140-5p与SMURF1调控肺动脉高压。
J Clin Invest. 2016 Jul 1;126(7):2495-508. doi: 10.1172/JCI83361. Epub 2016 May 23.
5
Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.Runt 相关转录因子 2 在肺动脉高压增殖性和钙化性血管病变中的作用。
Am J Respir Crit Care Med. 2016 Nov 15;194(10):1273-1285. doi: 10.1164/rccm.201512-2380OC.
6
HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.HIPPO-整合素连接激酶相互作用调控肺动脉高压中的自我持续增殖与存活
Am J Respir Crit Care Med. 2016 Oct 1;194(7):866-877. doi: 10.1164/rccm.201510-2003OC.
7
Diverse human extracellular RNAs are widely detected in human plasma.在人血浆中广泛检测到多种人类细胞外RNA。
Nat Commun. 2016 Apr 26;7:11106. doi: 10.1038/ncomms11106.
8
Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.特发性肺动脉高压中的关键基因组网络与血管反应性变异体
Am J Respir Crit Care Med. 2016 Aug 15;194(4):464-75. doi: 10.1164/rccm.201508-1678OC.
9
microRNA and Pulmonary Hypertension.微小RNA与肺动脉高压
Adv Exp Med Biol. 2015;888:237-52. doi: 10.1007/978-3-319-22671-2_12.
10
The Reactome pathway Knowledgebase.Reactome通路知识库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7. doi: 10.1093/nar/gkv1351. Epub 2015 Dec 9.